Applications of the phage display technology in molecular biology, biotechnology and medicine

References

• Abbas M, Ovais M, Chen C. 2020. Phage capsid nanoparticles as multivalent inhibitors of viral infections. Sci Bull (Beijing). 65(24):2050–2052.
   PubMed Web of Science ®Google Scholar
• Abbott RC, Cross RS, Jenkins MR. 2020. Finding the keys to the CAR: identifying novel target antigens for T cell redirection immunotherapies. IJMS. 21(2):515.
   Google Scholar
• Aghabeigi N, Lindsey N, Zamani A, Shishaeyan B. 2012. Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients. Iran. J. Public Health. 41:53–62. http://www.ncbi.nlm.nih.gov/pubmed/23113135
   PubMed Web of Science ®Google Scholar
• Aghebati-Maleki L, Bakhshinejad B, Baradaran B, Motallebnezhad M, Aghebati-Maleki A, Nickho H, Yousefi M, Majidi J. 2016. Phage display as a promising approach for vaccine development. J Biomed Sci. 23(1):66.
   PubMed Web of Science ®Google Scholar
• Ali MG, Zhang Z, Gao Q, Pan M, Rowan EG, Zhang J. 2020. Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview. Immunol Res. 68(6):325–339.
   PubMed Web of Science ®Google Scholar
• Alijaj N, Moutel S, Gouveia ZL, Gray M, Roveri M, Dzhumashev D, Weber F, Meier G, Luciani P, Rössler JK, et al. 2020. Novel FGFR4-targeting single-domain antibodies for multiple targeted therapies against rhabdomyosarcoma. Cancers (Basel). 12(11):3313.
   PubMed Web of Science ®Google Scholar
• An P, Lei H, Zhang J, Song S, He L, Jin G, Liu X, Wu J, Meng L, Liu M, et al. 2004. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library. Int J Cancer. 111(2):165–173.
   PubMed Web of Science ®Google Scholar
• Anand T, Virmani N, Bera BC, Vaid RK, Vashisth M, Bardajatya P, Kumar A, Tripathi BN. 2021. Phage display technique as a tool for diagnosis and antibody selection for coronaviruses. Curr Microbiol. 78(4):1124–1134.
   PubMed Web of Science ®Google Scholar
• Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279(5349):377–380.
   PubMed Web of Science ®Google Scholar
• Asar M, Newton-Northup J, Deutscher S, Soendergaard M. 2019. Ovarian cancer targeting phage for in vivo near-infrared optical imaging. Diagnostics. 9(4):183.
   Web of Science ®Google Scholar
• Azzazy HME, Highsmith WE. 2002. Phage display technology: clinical applications and recent innovations. Clin Biochem. 35(6):425–445.
   PubMed Web of Science ®Google Scholar
• Bailon Calderon H, Yaniro Coronel VO, Cáceres Rey OA, Colque Alave EG, Leiva Duran WJ, Padilla Rojas C, Montejo Arevalo H, García Neyra D, Galarza Pérez M, Bonilla C, et al. 2020. Development of nanobodies against hemorrhagic and myotoxic components of bothrops atrox snake venom. Front Immunol. 11:655.
   PubMed Web of Science ®Google Scholar
• Bakhshinejad B, Karimi M, Khalaj-Kondori M. 2015. Phage display: development of nanocarriers for targeted drug delivery to the brain. Neural Regen Res. 10(6):862–865.
   PubMed Web of Science ®Google Scholar
• Bar H, Yacoby I, Benhar I. 2008. Killing cancer cells by targeted drug-carrying phage nanomedicines. BMC Biotechnol. 8(1):37.
   PubMedGoogle Scholar
• Barinka C, Ptacek J, Richter A, Novakova Z, Morath V, Skerra A. 2016. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA). Protein Eng Des Sel. 29(3):105–115.
   PubMed Web of Science ®Google Scholar
• Barr RK, Verdile G, Wijaya LK, Morici M, Taddei K, Gupta VB, Pedrini S, Jin L, Nicolazzo JA, Knock E, et al. 2016. Validation and characterization of a novel peptide that binds monomeric and aggregated β-amyloid and inhibits the formation of neurotoxic oligomers. J Biol Chem. 291(2):547–559.
   PubMed Web of Science ®Google Scholar
• Bedi D, Gillespie JW, Petrenko VA. 2014. Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Eng Des Sel. 27(7):235–243.
   PubMed Web of Science ®Google Scholar
• Bhasin A, Drago NP, Majumdar S, Sanders EC, Weiss GA, Penner RM. 2020. Viruses masquerading as antibodies in biosensors: the development of the virus BioResistor. Acc Chem Res. 53(10):2384–2394.
   PubMed Web of Science ®Google Scholar
• Bhasin A, Ogata AF, Briggs JS, Tam PY, Tan MX, Weiss GA, Penner RM. 2018. The virus bioresistor: wiring virus particles for the direct, label-free detection of target proteins. Nano Lett. 18(6):3623–3629.
   PubMed Web of Science ®Google Scholar
• Bhasin A, Sanders EC, Ziegler JM, Briggs JS, Drago NP, Attar AM, Santos AM, True MY, Ogata AF, Yoon DV, et al. 2020. Virus Bioresistor (VBR) for detection of bladder cancer marker DJ-1 in urine at 10 pM in one minute. Anal Chem. 92(9):6654–6666.
   PubMed Web of Science ®Google Scholar
• Bhoj VG, Li L, Parvathaneni K, Zhang Z, Kacir S, Arhontoulis D, Zhou K, McGettigan-Croce B, Nunez-Cruz S, Gulendran G, et al. 2021. Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4. Mol Ther Oncolytics. 20:387–398.
   PubMed Web of Science ®Google Scholar
• Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC. 2000. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 19:1525–1533.
   PubMed Web of Science ®Google Scholar
• Bonvin P, Dunn SM, Rousseau F, Dyer DP, Shaw J, Power CA, Handel TM, Proudfoot AEI. 2014. Identification of the pharmacophore of the CC chemokine-binding proteins evasin-1 and -4 using phage display. J Biol Chem. 289(46):31846–31855.
   PubMed Web of Science ®Google Scholar
• Bonvin P, Power C, Proudfoot A, Dunn S. 2016. Mutagenesis by phage display. Methods Enzymol. 570:187–205.
   Google Scholar
• Braun R, Schönberger N, Vinke S, Lederer F, Kalinowski J, Pollmann K. 2020. Application of Next Generation Sequencing (NGS) in Phage Displayed Peptide Selection to Support the Identification of Arsenic-Binding Motifs. Viruses. 12(12):1360.
   PubMed Web of Science ®Google Scholar
• Burioni R, Williamson RA, Sanna PP, Bloom FE, Burton DR. 1994. Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci U S A. 91(1):355–359.
   PubMed Web of Science ®Google Scholar
• Cai XM, Xie HL, Liu MZ, Zha XL. 2008. Inhibition of cell growth and invasion by epidermal growth factor-targeted phagemid particles carrying siRNA against focal adhesion kinase in the presence of hydroxycamptothecin. BMC Biotechnol. 8(1):74.
   PubMedGoogle Scholar
• Campos LB, Pucca MB, Silva LC, Pessenda G, Filardi BA, Cerni FA, Oliveira IS, Laustsen AH, Arantes EC, Barbosa JE. 2020. Identification of cross-reactive human single-chain variable fragments against phospholipases A2 from Lachesis muta and Bothrops spp venoms. Toxicon. 184:116–121.
   PubMed Web of Science ®Google Scholar
• Cao B, Yang M, Mao C. 2016. Phage as a genetically modifiable supramacromolecule in chemistry, materials and medicine. Acc Chem Res. 49(6):1111–1120.
   PubMed Web of Science ®Google Scholar
• Chan SK, Lim TS. 2017. Immune human antibody libraries for infectious diseases. Adv Exp. Med Biol. 1053:61–78.
   Google Scholar
• Chen J, Huang Y, Zhu C, Li Q, Wu Y, Liu Q, Cheng Q. 2019. Early detection of Alzheimer’s disease by peptides from phage display screening. Brain Res. 1721:146306.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang L, Tang A, Callahan C, Pristatsky P, Swoyer R, Cejas P, Nahas D, Galli J, Cosmi S, et al. 2016. Discovery and characterization of phage display-derived human monoclonal antibodies against RSV F glycoprotein. PLoS One. 11(6):e0156798.
   PubMed Web of Science ®Google Scholar
• Chowdhury PS, Viner JL, Beers R, Pastan I. 1998. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci U S A. 95(2):669–674.
   PubMed Web of Science ®Google Scholar
• Chu X, Hou M, Peng J, Zhu Y, Zhang F, Ji X, Wang L, Ma D. 2006. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments. Blood Coagul Fibrinolysis. 17(5):403–407.
   PubMed Web of Science ®Google Scholar
• Chu XX, Hou M, Peng J, Zhu YY, Ji XH, Wang L, Zhang F, Ma DX. 2006. Effects of IgG and its F(ab′)2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation. Eur J Haematol. 76(2):153–159.
   PubMed Web of Science ®Google Scholar
• Cohen BA, Bergkvist M. 2013. Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids. J Photochem Photobiol B. 121:67–74.
   PubMed Web of Science ®Google Scholar
• Cohen ES, Dobson CL, Käck H, Wang B, Sims DA, Lloyd CO, England E, Rees DG, Guo H, Karagiannis SN, et al. 2014. A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma. MAbs. 6(3):756–764.
   PubMedGoogle Scholar
• Corti A, Curnis F, Arap W, Pasqualini R. 2008. The neovasculature homing motif NGR: more than meets the eye. Blood. 112(7):2628–2635.
   PubMed Web of Science ®Google Scholar
• Cortini A, Bembich S, Marson L, Cocco E, Edomi P. 2019. Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach. PLoS One. 14(12):e0226162.
   PubMed Web of Science ®Google Scholar
• Costa LE, Goulart LR, De Jesus Pereira NC, Lima MIS, Duarte MC, Martins VT, Lage PS, Menezes-Souza D, Ribeiro TG, Melo MN, et al. 2014. Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis. PLoS One. 9(10):e110014.
   PubMed Web of Science ®Google Scholar
• Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A. 2000. Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD 13). Nat Biotechnol. 18(11):1185–1190.
   PubMed Web of Science ®Google Scholar
• De Plano LM, Carnazza S, Franco D, Rizzo MG, Conoci S, Petralia S, Nicoletti A, Zappia M, Campolo M, Esposito E, et al. 2020. Innovative IgG biomarkers based on phage display microbial amyloid mimotope for state and stage diagnosis in Alzheimer’s disease. ACS Chem Neurosci. 11(7):1013–1026.
   PubMed Web of Science ®Google Scholar
• De Plano LM, Fazio E, Rizzo MG, Franco D, Carnazza S, Trusso S, Neri F, Guglielmino SPP. 2019. Phage-based assay for rapid detection of bacterial pathogens in blood by Raman spectroscopy. J Immunol Methods. 465:45–52.
   PubMed Web of Science ®Google Scholar
• De Vita F, Borg C, Farina G, Geva R, Carton I, Cuku H, Wei R, Muro K. 2019. Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW study. Future Oncol. 15(23):2723–2731.
   PubMed Web of Science ®Google Scholar
• Deken MM, Kijanka MM, Beltrán Hernández I, Slooter MD, de Bruijn HS, van Diest PJ, van Bergen En Henegouwen PMP, Lowik CWGM, Robinson DJ, Vahrmeijer AL, et al. 2020. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session. J Control Release. 323:269–281.
   PubMed Web of Science ®Google Scholar
• DePorter SM, McNaughton BR. 2014. Engineered M13 bacteriophage nanocarriers for intracellular delivery of exogenous proteins to human prostate cancer cells. Bioconjug Chem. 25(9):1620–1625.
   PubMed Web of Science ®Google Scholar
• Dervenis N, Mikropoulou AM, Tranos P, Dervenis P. 2017. Ranibizumab in the treatment of diabetic macular edema: a review of the current status, unmet needs, and emerging challenges. Adv Ther. 34(6):1270–1282.
   PubMed Web of Science ®Google Scholar
• Dókus LE, Lajkó E, Ranđelović I, Mező D, Schlosser G, Kőhidai L, Tóvári J, Mező G. 2020. Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to panc-1 pancreatic cancer. Pharmaceutics. 12(6):576.
   PubMed Web of Science ®Google Scholar
• Dorresteijn B, Rotman M, Faber D, Schravesande R, Suidgeest E, Van Der Weerd L, Van Der Maarel SM, Verrips CT, El Khattabi M. 2015. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo. FEBS J. 282(18):3618–3631.
   PubMed Web of Science ®Google Scholar
• Du B, Han H, Wang Z, Kuang L, Wang L, Yu L, Wu M, Zhou Z, Qian M. 2010. Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res. 8(2):135–144.
   PubMed Web of Science ®Google Scholar
• Du T, Zhu G, Wu X, Fang J, Zhou EM. 2019. Biotinylated single-domain antibody-based blocking ELISA for detection of antibodies against swine influenza virus. Int J Nanomedicine. 14:9337–9349.
   PubMed Web of Science ®Google Scholar
• Duval M, Posner MR, Cavacini LA. 2008. A bispecific antibody composed of a nonneutralizing antibody to the gp41 immunodominant region and an anti-CD89 antibody directs broad human immunodeficiency virus destruction by neutrophils. J Virol. 82(9):4671–4674.
   PubMed Web of Science ®Google Scholar
• Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R, Ruoslahti E, et al. 1999. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med. 5(9):1032–1038.
   PubMed Web of Science ®Google Scholar
• Ferrara F, Soluri MF, Sblattero D. 2019. Recombinant antibody selections by combining phage and yeast display. Methods Mol Biol. 1904:339–352.
   Google Scholar
• Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Alam SM, Tomaras GD, Ochsenbauer C, et al. 2011. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. J Virol. 85(14):7029–7036.
   PubMed Web of Science ®Google Scholar
• Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, Martins SF, Baltazar F, Rodrigues LR. 2019. Rational identification of a colorectal cancer targeting peptide through phage display. Sci Rep. 9(1):3958.
   PubMedGoogle Scholar
• Foglizzo V, Marchiò S. 2021. Bacteriophages as therapeutic and diagnostic vehicles in cancer. Pharmaceuticals. 14(2):161.
   Web of Science ®Google Scholar
• Føns S, Ledsgaard L, Nikolaev MV, Vassilevski AA, Sørensen CV, Chevalier MK, Fiebig M, Laustsen AH. 2020. Discovery of a recombinant human monoclonal immunoglobulin g antibody against α-latrotoxin from the Mediterranean black widow spider (Latrodectus tredecimguttatus). Front Immunol. 11:587825.
   PubMed Web of Science ®Google Scholar
• Fox JM, Roy V, Gunn BM, Huang L, Edeling MA, Mack M, Fremont DH, Doranz BJ, Johnson S, Alter G, et al. 2019. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcR interaction on monocytes. Sci. Immunol. 4(32):eaav5062.
   PubMed Web of Science ®Google Scholar
• Franco YL, Vaidya TR, Ait-Oudhia S. 2018. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer. Breast Cancer (Dove Med Press). 10:131–141.
   PubMed Web of Science ®Google Scholar
• Frenkel D, Dori M, Solomon B. 2004. Generation of anti-β-amyloid antibodies via phage display technology. Vaccine. 22(19):2505–2508.
   PubMed Web of Science ®Google Scholar
• Fühner V, Heine PA, Zilkens KJC, Meier D, Roth KDR, Moreira GMSG, Hust M, Russo G. 2019. Epitope mapping via phage display from single-gene libraries. Methods Mol Biol. 1904:353–375.
   Google Scholar
• Fukuta T, Asai T, Kiyokawa Y, Nakada T, Bessyo-Hirashima K, Fukaya N, Hyodo K, Takase K, Kikuchi H, Oku N. 2017. Targeted delivery of anticancer drugs to tumor vessels by use of liposomes modified with a peptide identified by phage biopanning with human endothelial progenitor cells. Int J Pharm. 524(1–2):364–372.
   PubMedGoogle Scholar
• Funayama JC, Pucca MB, Roncolato EC, Bertolini TB, Campos LB, Barbosa JE. 2012. Production of human antibody fragments binding to melittin and phospholipase a2 in Africanised bee venom: minimising venom toxicity. Basic Clin Pharmacol Toxicol. 110(3):290–297.
   PubMed Web of Science ®Google Scholar
• Gandra N, Abbineni G, Qu X, Huai Y, Wang L, Mao C. 2013. Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy. Small. 9(2):215–221.
   PubMed Web of Science ®Google Scholar
• Gao H, Qian J, Cao S, Yang Z, Pang Z, Pan S, Fan L, Xi Z, Jiang X, Zhang Q. 2012. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials. 33(20):5115–5123.
   PubMed Web of Science ®Google Scholar
• Garg P. 2019. Filamentous bacteriophage: a prospective platform for targeting drugs in phage-mediated cancer therapy. J Cancer Res Ther. 15(Supplement):S1–S10.
   PubMedGoogle Scholar
• Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. 2005. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci. 46(2):726–733.
   PubMed Web of Science ®Google Scholar
• Gebauer M, Skerra A. 2020. Engineered protein scaffolds as next-generation therapeutics. Annu Rev Pharmacol Toxicol. 60:391–415.
   PubMed Web of Science ®Google Scholar
• Geoghegan EM, Zhang H, Desai PJ, Biragyn A, Markham RB. 2015. Antiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2. Antimicrob Agents Chemother. 59(1):527–535.
   PubMed Web of Science ®Google Scholar
• Gevorkian G, Manoutcharian K, Almagro JC, Govezensky T, Dominguez V. 1998. Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library. Clin Immunol Immunopathol. 86(3):305–309.
   PubMedGoogle Scholar
• Gevorkian G, Manoutcharian K, Govezensky T, Cano JA, Dominguez V, Santamaria H, Larralde C. 2000. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura. J Autoimmun. 15(1):33–40.
   PubMed Web of Science ®Google Scholar
• Ghadge GD, Kay BK, Drigotas C, Roos RP. 2019. Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice. Neurobiol Dis. 121:131–137.
   PubMed Web of Science ®Google Scholar
• Goh XT, Chua KH, Kee BP, Lim YAL. 2020. Identification of Plasmodium knowlesi merozoite surface protein-119 (PkMSP-119) novel binding peptides from a phage display library. Trop Med Int Health. 25(2):172–185.
   PubMed Web of Science ®Google Scholar
• Golec P, Karczewska-Golec J, Łoś M, Węgrzyn G. 2012. Novel ZnO-binding peptides obtained by the screening of a phage display peptide library. J Nanoparticle Res. 14:1218.
   PubMed Web of Science ®Google Scholar
• Golec P, Żelechowska K, Karczewska-Golec J, Karczewski J, Leśniewski A, Łoś M, Węgrzyn G, Kłonkowski AM. 2017. Bacteriophages as factories for Eu2O3 nanoparticle synthesis. Bioconjug Chem. 28(7):1834–1841.
   PubMed Web of Science ®Google Scholar
• Goracci M, Pignochino Y, Marchiò S. 2020. Phage display-based nanotechnology applications in cancer immunotherapy. Molecules. 25(4):843.
   PubMed Web of Science ®Google Scholar
• Goulart LR, da S. Ribeiro V, Costa-Cruz JM. 2017. Anti-parasitic antibodies from phage display. Adv Exp Med Biol. 1053:155–171.
   Google Scholar
• Gounni AS, Lamkhioued B, Koussih L, Ra C, Renzi PM, Hamid Q. 2001. Human neutrophils express the high-affinity receptor for immunoglobulin E (FcεRI): role in asthma. Faseb J. 15(6):940–949.
   PubMed Web of Science ®Google Scholar
• Grabowska A, Jameson C, Laing P, Jeansson S, Sj√∂gren-Jansson E, Taylor J, Cunningham A, Irving WL. 1999. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol. 80(7):1789–1798.
   PubMedGoogle Scholar
• Harada LK, Silva EC, Campos WF, Del Fiol FS, Vila M, Dąbrowska K, Krylov VN, Balcão VM. 2018. Biotechnological applications of bacteriophages: state of the art. Microbiol Res. 212-213:38–58.
   PubMed Web of Science ®Google Scholar
• Henry KA, Arbabi-Ghahroudi M, Scott JK. 2015. Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold. Front Microbiol. 6:755.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, et al. 2009. Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. J Clin Oncol. 27(21):3557–3565.
   PubMed Web of Science ®Google Scholar
• Hoyer W, Grönwall C, Jonsson A, Ståhl S, Härd T. 2008. Stabilization of a β-hairpin in monomeric Alzheimer’s amyloid-β peptide inhibits amyloid formation. Proc Natl Acad Sci U S A. 105(13):5099–5104.
   PubMed Web of Science ®Google Scholar
• Huang JX, Bishop-Hurley SL, Cooper MA. 2012. Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites. Antimicrob Agents Chemother. 56(9):4569–4582.
   PubMed Web of Science ®Google Scholar
• Hussack G, Arbabi-Ghahroudi M, MacKenzie CR, Tanha J. 2012. Isolation and characterization of clostridium difficile toxin-specific single-domain antibodies. Methods Mol Biol. 911:211–239.
   PubMedGoogle Scholar
• Huwait EA, Baghallab IM, Glabe CG, Abulnaja KO, Kumosani TA, Moselhy SS. 2020. Identification of amyloid antibodies for Alzheimer disease–immunotherapy. Arch Physiol Biochem. 128:1275–1282.
   PubMed Web of Science ®Google Scholar
• Hwang DE, Choi JM, Yang CS, Jae Lee J, Heu W, Jo EK, Kim HS. 2016. Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody. Biochem Biophys Res Commun. 477(4):1072–1077.
   PubMed Web of Science ®Google Scholar
• Ishima Y, Mimono A, Tuan Giam Chuang V, Fukuda T, Kusumoto K, Okuhira K, Suwa Y, Watanabe H, Ishida T, Morioka H, et al. 2020. Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer’s disease treatment. IUBMB Life. 72(4):641–651.
   PubMed Web of Science ®Google Scholar
• Jacobin M-J, Laroche-Traineau J, Little M, Keller A, Peter K, Welschof M, Nurden A, Clofent-Sanchez G. 2002. Human IgG monoclonal anti-α IIb β 3 -binding fragments derived from immunized donors using phage display. J Immunol. 168(4):2035–2045.
   PubMed Web of Science ®Google Scholar
• Jacobin MJ, Robert R, Pouns O, Laroche-Traineau J, Nurden A, Peter K, Little M, Clofent-Sanchez G. 2003. Improving selection of αIIbβ3-binding phage antibodies with increased reactivity derived from immunized donors. Clin Immunol. 108(3):199–210.
   PubMed Web of Science ®Google Scholar
• Jafari B, Pourseif MM, Barar J, Rafi MA, Omidi Y. 2019. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors. Expert Opin Drug Deliv. 16(6):583–605.
   PubMed Web of Science ®Google Scholar
• Jamal M, Bukhari S, Andleeb S, Ali M, Raza S, Nawaz MA, Hussain T, Rahman S. u, Shah SSA. 2019. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. J Basic Microbiol. 59(2):123–133.
   PubMed Web of Science ®Google Scholar
• Jaroszewicz W, Morcinek-Orłowska J, Pierzynowska K, Gaffke L, Węgrzyn G. 2022. Phage display and other peptide display technologies. FEMS Microbiol Rev. 46(2):fuab052.
   PubMed Web of Science ®Google Scholar
• Jiang N, Leithold LHE, Post J, Ziehm T, Mauler J, Gremer L, Cremer M, Schartmann E, Shah NJ, Kutzsche J, et al. 2015. Preclinical pharmacokinetic studies of the tritium labelled D-enantiomeric peptide D3 developed for the treatment of Alzheimer’s disease. PLoS One. 10(6):e0128553.
   PubMed Web of Science ®Google Scholar
• Ju Z, Sun W. 2017. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles. Drug Deliv. 24(1):1898–1908.
   PubMed Web of Science ®Google Scholar
• Kadkhodazadeh M, Rajabibazl M, Motedayen M, Shahidi S, Malekshahi ZV, Rahimpour A, Yarahmadi M. 2020. Isolation of polyclonal single-chain fragment variable (ScFv) antibodies against venomous snakes of Iran and evaluation of their capability in neutralizing the venom. Iran. J. Pharm. Res. 19:288–296.
   PubMedGoogle Scholar
• Kang CK, Jayasinha V, Martin PT. 2003. Identification of peptides that specifically bind Aβ1-40 amyloid in vitro and amyloid plaques in Alzheimer’s disease brain using phage display. Neurobiol Dis. 14(1):146–156.
   PubMed Web of Science ®Google Scholar
• Karimi M, Mirshekari H, Moosavi Basri SM, Bahrami S, Moghoofei M, Hamblin MR. 2016. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos. Adv Drug Deliv Rev. 106(Pt A):45–62.
   PubMedGoogle Scholar
• Karoonuthaisiri N, Charlermroj R, Morton MJ, Oplatowska-Stachowiak M, Grant IR, Elliott CT. 2014. Development of a M13 bacteriophage-based SPR detection using Salmonella as a case study. Sens Actuators B Chem. 190:214–220.
   Web of Science ®Google Scholar
• Kausmally L, Waalen K, Løbersli I, Hvattum E, Berntsen G, Michaelsen TE, Brekke OH. 2004. Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library. J Gen Virol. 85(Pt 12):3493–3500.
   PubMedGoogle Scholar
• Kawasaki M, Echiverri C, Raymond L, Cadena E, Reside E, Gler MT, Oda T, Ito R, Higashiyama R, Katsuragi K, et al. 2019. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: analytic validation and evaluation in two cohorts. PLoS Med. 16(4):e1002780.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Onodera K, Kamijo S. 2011. Identification of novel short peptide inhibitors of soluble 37/48 kDa oligomers of amyloid β42. Biosci Biotechnol Biochem. 75(8):1496–1501.
   PubMed Web of Science ®Google Scholar
• Kenan DJ, Strittmatter WJ, Burke JR. 2006. Phage display screening for peptides that inhibit polyglutamine aggregation. Methods Enzymol. 413:253–273.
   PubMed Web of Science ®Google Scholar
• Kenniston JA, Faucette RR, Martik D, Comeau SR, Lindberg AP, Kopacz KJ, Conley GP, Chen J, Viswanathan M, Kastrapeli N, et al. 2014. Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem. 289(34):23596–23608.
   PubMed Web of Science ®Google Scholar
• Khalili E, Lakzaei M, Rasaee MJ, Aminian M. 2015. Production of recombinant human scFv against tetanus toxin heavy chain by phage display technology. Monoclon Antib Immunodiagn Immunother. 34(5):303–309.
   PubMedGoogle Scholar
• Khan F, Gurung S, Gunassekaran GR, Vadevoo SMP, Chi L, Permpoon U, Haque ME, Lee YK, Lee SW, Kim S, et al. 2021. Identification of novel CD44v6-binding peptides that block CD44v6 and deliver a pro-apoptotic peptide to tumors to inhibit tumor growth and metastasis in mice. Theranostics. 11(3):1326–1344.
   PubMed Web of Science ®Google Scholar
• Kim H, Jang JH, Kim SC, Cho JH. 2020. Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa. Eur J Med Chem. 185:111814.
   PubMed Web of Science ®Google Scholar
• Kim HY, Lee JH, Kim MJ, Park SC, Choi M, Lee W, Ku KB, Kim BT, Changkyun Park E, Kim HG, et al. 2021. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins. Biosens Bioelectron. 175:112868.
   PubMed Web of Science ®Google Scholar
• Kim JH, Koh B, Ahn DG, Lee SJ, Park TJ, Park JP. 2021. A screening study of high affinity peptide as molecular binder for AXL, tyrosine kinase receptor involving in Zika virus entry. Bioelectrochemistry. 137:107670.
   PubMed Web of Science ®Google Scholar
• Kim MY, Kim OR, Choi YS, Lee H, Park K, Lee CT, Kang KW, Jeong S. 2012. Selection and characterization of tenascin C targeting peptide. Mol Cells. 33(1):71–77.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Dudley ME, Kassim SH, Somerville RPT, Carpenter RO, Maryalice SS, Yang JC, Phan GQ, Hughes MS, Sherry RM, et al. 2015. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol. 33(6):540–549.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DAN, Lanier BJ, et al. 2010. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood. 116(20):4099–4102.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, et al. 1999. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol. 17(8):768–774.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Wang B, Ruoslahti E. 1995. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrine. Biotechnology (N Y). 13(3):265–270.
   PubMedGoogle Scholar
• Kondo T, Iwatani Y, Matsuoka K, Fujino T, Umemoto S, Yokomaku Y, Ishizaki K, Kito S, Sezaki T, Hayashi G, et al. 2020. Antibody-like proteins that capture and neutralize SARS-CoV-2. Sci Adv. 6(42):eabd3916.
   PubMed Web of Science ®Google Scholar
• Koolpe M, Dail M, Pasquale EB. 2002. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem. 277(49):46974–46979.
   PubMed Web of Science ®Google Scholar
• Kuenen B, Witteveen PO, Ruijter R, Giaccone G, Dontabhaktuni A, Fox F, Katz T, Youssoufian H, Zhu J, Rowinsky EK, et al. 2010. A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies. Clin Cancer Res. 16(6):1915–1923.
   PubMed Web of Science ®Google Scholar
• Kumar C, Zito PM. 2021. Omalizumab. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/pubmed/31424767
   Google Scholar
• Kurabi A, Cooper M, Spriggs M, Xu Y, Schaerer D, Ryan AF. 2020. Molecular screening strategy to identify a non-invasive delivery mechanism for the treatment of middle ear disorders. Front Med (Lausanne). 7:503819.
   PubMed Web of Science ®Google Scholar
• Kurabi A, Pak KK, Bernhardt M, Baird A, Ryan AF. 2016. Discovery of a biological mechanism of active transport through the tympanic membrane to the middle ear. Sci Rep. 6:22663.
   PubMed Web of Science ®Google Scholar
• Kurabi A, Schaerer D, Chang L, Pak K, Ryan AF. 2018. Optimisation of peptides that actively cross the tympanic membrane by random amino acid extension: a phage display study. J Drug Target. 26(2):127–134.
   PubMed Web of Science ®Google Scholar
• Kwak MH, Yi G, Yang SM, Choe Y, Choi S, Soo Lee H, Kim E, Beom Lim Y, Na K, Choi MG, et al. 2020. A dodecapeptide selected by phage display as a potential theranostic probe for colon cancers. Transl Oncol. 13(9):100798.
   PubMed Web of Science ®Google Scholar
• Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F. 2009. Single-domain antibodies recognize selectively small oligomeric forms of amyloid β, prevent Aβ-induced neurotoxicity and inhibit fibril formation. Mol Immunol. 46(4):695–704.
   PubMed Web of Science ®Google Scholar
• Lavie V, Becker M, Cohen-Kupiec R, Yacoby I, Koppel R, Wedenig M, Hutter-Paier B, Solomon B. 2004. EFRH-phage immunization of Alzheimer’s disease animal model improves behavioral performance in Morris water maze trials, in. J Mol Neurosci. 24(1):105–113.
   PubMed Web of Science ®Google Scholar
• Lecerf JM, Shirley TL, Zhu Q, Kazantsev A, Amersdorfer P, Housman DE, Messer A, Huston JS. 2001. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington’s disease. Proc Natl Acad Sci U S A. 98(8):4764–4769.
   PubMed Web of Science ®Google Scholar
• Lederer FL, Curtis SB, Bachmann S, Dunbar WS, MacGillivray RTA. 2017. Identification of lanthanum-specific peptides for future recycling of rare earth elements from compact fluorescent lamps. Biotechnol Bioeng. 114(5):1016–1024.
   PubMed Web of Science ®Google Scholar
• Lee C-H, Lee Y-C, Lee Y-L, Leu S-J, Lin L-T, Chen C-C, Chiang J-R, Mwale P, Tsai B-Y, Hung C-S, et al. 2017. Single chain antibody fragment against venom from the snake Daboia russelii formosensis. Toxins (Basel). 9(11):347.
   PubMed Web of Science ®Google Scholar
• Lee CH, Liu CI, Leu SJ, Lee YC, Chiang JR, Chiang LC, Mao YC, Tsai BY, Hung CS, Chen CC, et al. 2020. Chicken antibodies against venom proteins of Trimeresurus stejnegeri in Taiwan. J. Venom Anim Toxins Incl Trop Dis. 26:e20200056.
   PubMed Web of Science ®Google Scholar
• Lee SC, Yoon MY. 2020. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization. Int J Biol Macromol. 163:327–335.
   PubMed Web of Science ®Google Scholar
• Lehmann A. 2006. Ecallantide (Dyax/Genzyme). Curr Opin Investig Drugs. 7(3):282–290.
   PubMedGoogle Scholar
• Leow CH, Jones M, Cheng Q, Mahler S, McCarthy J. 2014. Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2. Malar J. 13(1):277.
   Google Scholar
• Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, Chen J, Pang Z, Wang Y, Jiang X, et al. 2011. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 32(21):4943–4950.
   PubMed Web of Science ®Google Scholar
• Li Y, Qu X, Cao B, Yang T, Bao Q, Yue H, Zhang L, Zhang G, Wang L, Qiu P, et al. 2020. Selectively suppressing tumor angiogenesis for targeted breast cancer therapy by genetically engineered phage. Adv. Mater. 32(29):2001260.
   PubMed Web of Science ®Google Scholar
• Li YK, Wang XY, Liu X, Yang T, Chen ML, Wang JH. 2020. Ensuring high selectivity for preconcentration and detection of ultra-trace cadmium using a phage-functionalized metal-organic framework. Analyst. 145(15):5280–5288.
   PubMed Web of Science ®Google Scholar
• Lipovšek D. 2011. Adnectins: engineered target-binding protein therapeutics. Protein Eng. Des. Sel. 24:3–9.
   PubMed Web of Science ®Google Scholar
• Liu H, Funke SA, Willbold D. 2010. Transport of alzheimer disease amyloid-β-binding d-amino acid peptides across an in vitro blood-brain barrier model. Rejuvenation Res. 13(2-3):210–213.
   PubMed Web of Science ®Google Scholar
• Liu J, Cui D, Jiang Y, Li Y, Liu Z, Tao L, Zhao Q, Diao A. 2021. Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein. Int J Biol Macromol. 166:884–892.
   PubMed Web of Science ®Google Scholar
• Liu JL, Shriver-Lake LC, Zabetakis D, Anderson GP, Goldman ER. 2019. Selection and characterization of protective anti-chikungunya virus single domain antibodies. Mol Immunol. 105:190–197.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang C, Yu L, Shi Y, Zhang L, Peng J, Ji X, Hou M. 2016. Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library. Hematology. 21(1):60–67.
   PubMed Web of Science ®Google Scholar
• Liu S, Miersch S, Li P, Bai B, Liu C, Qin W, Su J, Huang H, Pan J, Sidhu SS, et al. 2020. A synthetic human antibody antagonizes IL-18Rβ signaling through an allosteric mechanism. J Mol Biol. 432(4):1169–1182.
   PubMed Web of Science ®Google Scholar
• Liu X, Gao F, Jiang L, Jia M, Ao L, Lu M, Gou L, Ho M, Jia S, Chen F, et al. 2020. 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma. J Transl Med. 18(1):295.
   PubMed Web of Science ®Google Scholar
• Lo A, Lin CT, Wu HC. 2008. Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery. Mol Cancer Ther. 7(3):579–589.
   PubMed Web of Science ®Google Scholar
• Lu G, Zheng M, Zhu Y, Sha M, Wu Y, Han X. 2012. Selection of peptide inhibitor to matrix Metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1. Int J Biol Sci. 8(5):650–662.
   PubMed Web of Science ®Google Scholar
• Lu S, Ascencio ME, Torquato RJS, Florin-Christensen M, Tanaka AS. 2020. Kinetic characterization of a novel cysteine peptidase from the protozoan Babesia bovis, a potential target for drug design. Biochimie. 179:127–134.
   PubMed Web of Science ®Google Scholar
• Lui BG, Salomon N, Wüstehube-Lausch J, Daneschdar M, Schmoldt HU, Türeci Ö, Sahin U. 2020. Targeting the tumor vasculature with engineered cystine-knot miniproteins. Nat Commun. 11(1):295.
   PubMed Web of Science ®Google Scholar
• Lynagh T, Kiontke S, Meyhoff-Madsen M, Gless BH, Johannesen J, Kattelmann S, Christiansen A, Dufva M, Laustsen AH, Devkota K, et al. 2020. Peptide inhibitors of the α-cobratoxin-nicotinic acetylcholine receptor interaction. J Med Chem. 63(22):13709–13718.
   PubMed Web of Science ®Google Scholar
• Ma L, Zhu M, Gai J, Li G, Chang Q, Qiao P, Cao L, Chen W, Zhang S, Wan Y. 2020. Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential. J Nanobiotechnol. 18(1):12.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Wei Z, Ikezoe Y, Tam E, Matsui H. 2016. Biomimetic crystallization of MnFe2O4mediated by peptide-catalyzed esterification at low temperature. ChemNanoMat. 2(5):419–422.
   PubMed Web of Science ®Google Scholar
• Magdesian MH, Nery AA, Martins AHB, Juliano MA, Juliano L, Ulrich H, Ferreira ST. 2005. Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid β. J Biol Chem. 280(35):31085–31090.
   PubMed Web of Science ®Google Scholar
• Majerova P, Hanes J, Olesova D, Sinsky J, Pilipcinec E, Kovac A. 2020. Novel blood–brain barrier shuttle peptides discovered through the phage display method. Molecules. 25(4):874.
   PubMed Web of Science ®Google Scholar
• Malcor JD, Payrot N, David M, Faucon A, Abouzid K, Jacquot G, Floquet N, Debarbieux F, Rougon G, Martinez J, et al. 2012. Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting. J Med Chem. 55(5):2227–2241.
   PubMed Web of Science ®Google Scholar
• Mao C, Flynn CE, Hayhurst A, Sweeney R, Qi J, Georgiou G, Iverson B, Belcher AM. 2003. Viral assembly of oriented quantum dot nanowires. Proc Natl Acad Sci USA. 100(12):6946–6951.
   PubMed Web of Science ®Google Scholar
• Mao J, Shi X, Wu YB, Gong SQ. 2016. Identification of specific hydroxyapatite {001} binding heptapeptide by phage display and its nucleation effect. Materials (Basel). 9(8):700.
   PubMed Web of Science ®Google Scholar
• Martins IM, Reis RL, Azevedo HS. 2016. Phage display technology in biomaterials engineering: progress and opportunities for applications in regenerative medicine. ACS Chem Biol. 11(11):2962–2980.
   PubMed Web of Science ®Google Scholar
• Middendorp SJ, Wilbs J, Quarroz C, Calzavarini S, Angelillo-Scherrer A, Heinis C. 2017. Peptide macrocycle inhibitor of coagulation factor XII with subnanomolar affinity and high target selectivity. J Med Chem. 60(3):1151–1158.
   PubMed Web of Science ®Google Scholar
• Miller CJ, McGinnis JE, Martinez MJ, Wang G, Zhou J, Simmons E, Amet T, Abdeen SJ, Van Huysse JW, Bowsher RR, et al. 2021. FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein. N Biotechnol. 62:79–85.
   PubMed Web of Science ®Google Scholar
• Monaco DR, Sie BM, Nirschl TR, Knight AC, Sampson HA, Nowak-Wegrzyn A, Wood RA, Hamilton RG, Frischmeyer-Guerrerio PA, Larman HB. 2021. Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes. Nat Commun. 12(1):379.
   PubMed Web of Science ®Google Scholar
• Mooi J, Chionh F, Savas P, Da Gama Duarte J, Chong G, Brown S, Wong R, Price T, Wann A, Skrinos E, et al. 2021. Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. Clin. Cancer Res. 27(8):2159–2167. clincanres.2714.2020.
   PubMed Web of Science ®Google Scholar
• Moon JS, Choi EJ, Jeong NN, Sohn JR, Han DW, Oh JW. 2019. Research progress of M13 bacteriophage-based biosensors. Nanomaterials. 9(10):1448.
   Web of Science ®Google Scholar
• Mu Y, Jia C, Zheng X, Zhu H, Zhang X, Xu H, Liu B, Zhao Q, Zhou EM. 2021. A nanobody‐horseradish peroxidase fusion protein‐based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2. J Nanobiotechnol. 19(1):34.
   PubMed Web of Science ®Google Scholar
• Munke A, Persson J, Weiffert T, De Genst E, Meisl G, Arosio P, Carnerup A, Dobson CM, Vendruscolo M, Knowles TPJ, et al. 2017. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication. Proc Natl Acad Sci U S A. 114(25):6444–6449.
   PubMed Web of Science ®Google Scholar
• Mwale PF, Lee CH, Lin LT, Leu SJ, Huang YJ, Chiang LC, Mao YC, Yang YY. 2020. Expression, purification, and characterization of anti-Zika virus envelope protein: polyclonal and chicken-derived single chain variable fragment antibodies. IJMS. 21(2):492.
   Google Scholar
• Nagai Y, Fujikake N, Ohno K, Higashiyama H, Popiel HA, Rahadian J, Yamaguchi M, Strittmatter WJ, Burke JR, Toda T. 2003. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Hum Mol Genet. 12(11):1253–1259.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Tucker T, Ren H, Kenan DJ, Henderson BS, Keene JD, Strittmatter WJ, Burke JR. 2000. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol Chem. 275(14):10437–10442.
   PubMed Web of Science ®Google Scholar
• Namdee K, Khongkow M, Boonrungsiman S, Nittayasut N, Asavarut P, Temisak S, Saengkrit N, Puttipipatkhachorn S, Hajitou A, Ruxrungtham K, et al. 2018. Thermoresponsive bacteriophage nanocarrier as a gene delivery vector targeted to the gastrointestinal tract. Mol Ther Nucleic Acids. 12:33–44.
   PubMedGoogle Scholar
• Nazari A, Samianifard M, Rabie H, Mirakabadi AZ. 2020. Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology. J Venom Anim Toxins Incl Trop Dis. 26:e20190099.
   PubMed Web of Science ®Google Scholar
• NDR, Prado, SS, Pereira, MP, Da Silva, MSS, Morais, AM, Kayano, LS, Moreira-Dill, MB, Luiz, FB, Zanchi, AL, Fuly, MEF, Huacca, et al. 2016. Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A2 by specific camelid single-domain antibody fragments. PLoS One. 11(3):e0151363.
   PubMed Web of Science ®Google Scholar
• Nixon AE, Sexton DJ, Ladner RC. 2014. Drugs derived from phage display from candidate identification to clinical practice. MAbs. 6(1):73–85.
   PubMed Web of Science ®Google Scholar
• Niyomdecha S, Limbut W, Numnuam A, Kanatharana P, Charlermroj R, Karoonuthaisiri N, Thavarungkul P. 2018. Phage-based capacitive biosensor for Salmonella detection. Talanta. 188:658–664.
   PubMed Web of Science ®Google Scholar
• O’Donovan B, Mandel-Brehm C, Vazquez SE, Liu J, Parent AV, Anderson MS, Kassimatis T, Zekeridou A, Hauser SL, Pittock SJ, et al. 2020. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display. Brain Commun. 2:fcaa059.
   Google Scholar
• Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ, et al. 2004. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell. 6(5):507–516.
   PubMed Web of Science ®Google Scholar
• Omidfar K, Daneshpour M. 2015. Advances in phage display technology for drug discovery. Expert Opin Drug Discov. 10(6):651–669.
   PubMed Web of Science ®Google Scholar
• Oo KK, Kamolhan T, Soni A, Thongchot S, Mitrpant C, O-Charoenrat P, Thuwajit C, Thuwajit P. 2021. Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer. BMC Cancer. 21(1):65.
   PubMed Web of Science ®Google Scholar
• Pande J, Szewczyk MM, Grover AK. 2010. Phage display: concept, innovations, applications and future. Biotechnol Adv. 28(6):849–858.
   PubMed Web of Science ®Google Scholar
• Panousis C, Dhagat U, Edwards KM, Rayzman V, Hardy MP, Braley H, Gauvreau GM, Hercus TR, Smith S, Sehmi R, et al. 2016. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. MAbs. 8(3):436–453.
   PubMed Web of Science ®Google Scholar
• Park M. 2020. Surface display technology for biosensor applications: a review. Sensors (Switzerland). 20(10):2775.
   PubMed Web of Science ®Google Scholar
• Paz-Ares L, Socinski MA, Shahidi J, Hozak RR, Soldatenkova V, Kurek R, Varella-Garcia M, Thatcher N, Hirsch FR. 2016. Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer. Ann Oncol. 27(8):1573–1579.
   PubMed Web of Science ®Google Scholar
• Peltomaa R, Benito-Peña E, Barderas R, Moreno-Bondi MC. 2019. Phage display in the quest for new selective recognition elements for biosensors. ACS Omega. 4(7):11569–11580.
   PubMed Web of Science ®Google Scholar
• Peltomaa R, López-Perolio I, Benito-Peña E, Barderas R, Moreno-Bondi MC. 2016. Application of bacteriophages in sensor development. Anal Bioanal Chem. 408(7):1805–1828.
   PubMed Web of Science ®Google Scholar
• Pereira AC, Ferreira D, Santos-Pereira C, Vieira TF, Sousa SF, Sales G, Rodrigues LR. 2021. Selection of a new peptide homing SK-BR-3 breast cancer cells. Chem Biol Drug Des. 97(4):893–903.
   PubMed Web of Science ®Google Scholar
• Pero SC, Shukla GS, Armstrong AL, Peterson D, Fuller SP, Godin K, Kingsley-Richards SL, Weaver DL, Bond J, Krag DN. 2004. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells. Int J Cancer. 111(6):951–960.
   PubMed Web of Science ®Google Scholar
• Pessenda G, Silva LC, Campos LB, Pacello EM, Pucca MB, Martinez EZ, Barbosa JE. 2016. Human scFv antibodies (Afribumabs) against Africanized bee venom: advances in melittin recognition. Toxicon. 112:59–67.
   PubMed Web of Science ®Google Scholar
• Petrenko VA. 2018. Landscape phage: evolution from phage display to nanobiotechnology. Viruses. 10(6):311.
   PubMed Web of Science ®Google Scholar
• Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, et al. 2020. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial. Lancet Oncol. 21(1):105–120.
   PubMed Web of Science ®Google Scholar
• Popiel HA, Burke JR, Strittmatter WJ, Oishi S, Fujii N, Takeuchi T, Toda T, Wada K, Nagai Y. 2011. The aggregation inhibitor peptide QBP1 as a therapeutic molecule for the polyglutamine neurodegenerative diseases. J Amino Acids. 2011:265084.
   PubMedGoogle Scholar
• Prades R, Guerrero S, Araya E, Molina C, Salas E, Zurita E, Selva J, Egea G, López-Iglesias C, Teixidó M, et al. 2012. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials. 33(29):7194–7205.
   PubMed Web of Science ®Google Scholar
• Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, et al. 2012. The PSA-/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell. 10(5):556–569.
   PubMed Web of Science ®Google Scholar
• Quaden D, Vandormael P, Ruytinx P, Geusens P, Corten K, Vanhoof J, Liesenborgs J, van Reeth F, Agten A, Vandenabeele F, et al. 2020. Antibodies against three novel peptides in early axial spondyloarthritis patients from two independent cohorts. Arthritis Rheumatol. 72(12):2094–2105.
   PubMed Web of Science ®Google Scholar
• Raats JMH, Wijnen EM, Pruijn GJM, van den Hoogen FHJ, van Venrooij WJ. 2003. Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J. Rheumatol. 30:1696–1711.
   PubMed Web of Science ®Google Scholar
• Rahimzadeh G, Gill P, Rezai MS. 2020. Cysteine/histidine-dependent amidohydrolase/peptidase (Chap)-displayed nano phages: antimicrobial function against methicillin-resistant Staphylococcus aureus (MRSA). Avicenna J Med Biotechnol. 12(2):85–90.//pubmed.ncbi.nlm.nih.gov/32431792/. (accessed March 26, 2021).
   PubMedGoogle Scholar
• Ramaraju H, Miller SJ, Kohn DH. 2017. Dual-functioning peptides discovered by phage display increase the magnitude and specificity of BMSC attachment to mineralized biomaterials. Biomaterials. 134:1–12.
   PubMed Web of Science ®Google Scholar
• Rauth S, Hinz D, Börger M, Uhrig M, Mayhaus M, Riemenschneider M, Skerra A. 2016. High-affinity anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide. Biochem J. 473(11):1563–1578.
   PubMedGoogle Scholar
• Read J, Suphioglu C. 2019. Identification of a BACE1 binding peptide candidate for the prevention of Amyloid beta in Alzheimer’s disease. Cell. Physiol. Biochem. 53:413–428.
   PubMedGoogle Scholar
• Renschler MF, Bhatt RR, Dower WJ, Levy R. 1994. Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma. Proc Natl Acad Sci U S A. 91(9):3623–3627.
   PubMed Web of Science ®Google Scholar
• Richter A, Skerra A. 2017. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging. Biol Chem. 398(1):39–55.
   PubMed Web of Science ®Google Scholar
• Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP. 2003. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg. 25(1):16–22.
   PubMed Web of Science ®Google Scholar
• Roncolato EC, Campos LB, Pessenda G, Costa E Silva L, Furtado GP, Barbosa JE. 2015. Phage display as a novel promising antivenom therapy: a review. Toxicon. 93:79–84.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. 2006. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 355(14):1419–1431.
   PubMed Web of Science ®Google Scholar
• Roshan R, Naderi S, Behdani M, Cohan RA, Ghaderi H, Shokrgozar MA, Golkar M, Kazemi-Lomedasht F. 2021. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy. Mol Immunol. 129:70–77.
   PubMed Web of Science ®Google Scholar
• Rossotti MA, González-Techera A, Guarnaschelli J, Yim L, Camacho X, Fernández M, Cabral P, Leizagoyen C, Chabalgoity JA, González-Sapienza G. 2015. Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain. MAbs. 7(5):820–828.
   PubMed Web of Science ®Google Scholar
• Sadam H, Pihlak A, Jaago M, Pupina N, Rähni A, Toots M, Vaheri A, Nieminen JK, Siuko M, Tienari PJ, et al. 2021. Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients. EBioMedicine. 64:103211.
   PubMed Web of Science ®Google Scholar
• Sáenz-Garcia JL, Yamanaka IB, Pacheco-Lugo LA, Miranda JS, Córneo ES, Machado-de-Ávila RA, De Moura JF, DaRocha WD. 2020. Targeting epimastigotes of Trypanosoma cruzi with a peptide isolated from a phage display random library. Exp Parasitol. 210:107830.
   PubMed Web of Science ®Google Scholar
• San Segundo-Acosta P, Montero-Calle A, Fuentes M, Rábano A, Villalba M, Barderas R. 2019. Identification of Alzheimer’s disease autoantibodies and their target biomarkers by phage microarrays. J Proteome Res. 18(7):2940–2953.
   PubMed Web of Science ®Google Scholar
• Sanghvi AB, Miller KPH, Belcher AM, Schmidt CE. 2005. Biomaterials functionalization using a novel peptide that selectively binds to a conducting polymer. Nat Mater. 4(6):496–502.
   PubMed Web of Science ®Google Scholar
• Sanna PP, Williamson RA, De Logu A, Bloom FE, Burton DR. 1995. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci USA. 92(14):6439–6443.
   PubMed Web of Science ®Google Scholar
• Saw PE, Kim S, Lee IH, Park J, Yu M, Lee J, Kim JI, Jon S. 2013. Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy. J Mater Chem B. 1(37):4723–4726.
   PubMed Web of Science ®Google Scholar
• Saw PE, Song EW. 2019. Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein Cell. 10(11):787–807.
   PubMed Web of Science ®Google Scholar
• Sblattero D, Florian F, Not T, Ventura A, Bradbury A, Marzari R. 2000. Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries. Hum Antibodies. 9(4):199–205.
   PubMedGoogle Scholar
• Schirrmann T, Hust M. 2010. Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol. 651:177–209.
   PubMedGoogle Scholar
• Schlehuber S, Skerra A. 2005. Anticalins as an alternative to antibody technology. Expert Opin Biol Ther. 5(11):1453–1462.
   PubMed Web of Science ®Google Scholar
• Seidel-Greven M, Addai-Mensah O, Spiegel H, Chiegoua Dipah GN, Schmitz S, Breuer G, Frempong M, Reimann A, Klockenbring T, Fischer R, et al. 2021. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity. Malar J. 20(1):37.
   PubMedGoogle Scholar
• Shadidi M, Sioud M. 2003. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J. 17(2):256–258.
   PubMedGoogle Scholar
• Shakib F, Hooi DSW, Smith SJ, Viciene RF, Sewell HF. 2000. Identification of peptide motifs recognized by a human IgG autoanti-IgE antibody using a phage display library. Clin Exp Allergy. 30(7):1041–1046.
   PubMed Web of Science ®Google Scholar
• Shamsuddin SH, Jayne DG, Tomlinson DC, McPherson MJ, Millner PA. 2021. Selection and characterisation of Affimers specific for CEA recognition. Sci Rep. 11(1):744.
   PubMed Web of Science ®Google Scholar
• Shi F, Gan L, Wang Y, Wang P. 2020. Impedimetric biosensor fabricated with affinity peptides for sensitive detection of Escherichia coli O157: H7. Biotechnol Lett. 42(5):825–832.
   PubMed Web of Science ®Google Scholar
• Shu M, Yan H, Xu C, Wu Y, Chi Z, Nian W, He Z, Xiao J, Wei H, Zhou Q, et al. 2020. A novel anti-HER2 antibody GB235 reverses trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo. Sci Rep. 10(1):1–2.
   PubMed Web of Science ®Google Scholar
• Sidhu SS. 2000. Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol. 11(6):610–616.
   PubMed Web of Science ®Google Scholar
• Singh A, Arutyunov D, Szymanski CM, Evoy S. 2012. Bacteriophage based probes for pathogen detection. Analyst. 137(15):3405–3421.,
   PubMed Web of Science ®Google Scholar
• Sioud M, Mobergslien A. 2012. Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide. Biochem Pharmacol. 84(9):1123–1132.
   PubMed Web of Science ®Google Scholar
• Sioud M. 2019. Phage display libraries: from binders to targeted drug delivery and human therapeutics. Mol Biotechnol. 61(4):286–303.
   PubMed Web of Science ®Google Scholar
• Solomon B, Frenkel D. 2002. Generation and brain delivery of anti-aggregating antibodies against β-amyloid plaques using phage display technology. J Neural Transm Suppl. (62):321–325.
   Google Scholar
• Solomon B. 2005. Generation of anti-β-amyloid antibodies via phage display technology towards Alzheimer’s disease vaccination. Vaccine. 23: 2327–2330.
   Google Scholar
• Solomon B. 2007. Active immunization against Alzheimer’s β-amyloid peptide using phage display technology. Vaccine. 25(16):3053–3056.
   PubMed Web of Science ®Google Scholar
• Somers K, Geusens P, Elewaut D, De Keyser F, Rummens JL, Coenen M, Blom M, Stinissen P, Somers V. 2011. Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun. 36(1):33–46.
   PubMed Web of Science ®Google Scholar
• Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O’Bryant C, Chow LQM, Serkova NJ, et al. 2010. Phase I pharmacologic and biologic study of ramucirumab (imc-1121b), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. J Clin Oncol. 28(5):780–787.
   PubMed Web of Science ®Google Scholar
• Ståhl S, Gräslund T, Eriksson Karlström A, Frejd FY, Nygren PÅ, Löfblom J. 2017. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 35(8):691–712.
   PubMed Web of Science ®Google Scholar
• Stumpp MT, Dawson KM, Binz HK. 2020. Beyond antibodies: the DARPin® drug platform. BioDrugs. 34(4):423–433.
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang X, Bidlingmaier S, Behrens CR, Lee NK, Liu B. 2020. ALPPL2 is a highly specific and targetable tumor cell surface antigen. Cancer Res. 80(20):4552–4564.
   PubMed Web of Science ®Google Scholar
• Sui Y, Zhu R, Hu W, Zhang W, Zhu H, Gong M, Gao L, Cao T, Tang T, Yu B, et al. 2021. Phage display screening identifies a prostate specific antigen (PSA)–/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancer. Transl Oncol. 14(3):101020.
   PubMed Web of Science ®Google Scholar
• Suthiwangcharoen N, Li T, Li K, Thompson P, You S, Wang Q. 2011. M13 bacteriophage-polymer nanoassemblies as drug delivery vehicles. Nano Res. 4(5):483–493.
   Web of Science ®Google Scholar
• Szakács D, Kocsis A, Szász R, Gál P, Pál G. 2019. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors. J Biol Chem. 294(20):8227–8237.
   PubMed Web of Science ®Google Scholar
• Szot-Karpińska K, Golec P, Leśniewski A, Pałys B, Marken F, Niedziółka-Jönsson J, Wȩgrzyn G, Łoś M. 2016. Modified filamentous bacteriophage as a scaffold for carbon nanofiber. Bioconjug Chem. 27(12):2900–2910.
   PubMed Web of Science ®Google Scholar
• Tadano H, Tsukahara T, Mizushima E, Akamatsu A, Watanabe K, Nojima I, Kubo T, Kanaseki T, Hirohashi Y, Sato N, et al. 2020. Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8. Br J Cancer. 123(9):1387–1394.
   PubMed Web of Science ®Google Scholar
• Tajiri M. 2021. Phage display screening for alba superfamily proteins from the human malaria parasite, plasmodium falciparum reveals a high level of association with protein modification pathways and hints at new drug targets. Acta Parasit. 66(3):844–850.
   PubMed Web of Science ®Google Scholar
• Tan Y, Tian T, Liu W, Zhu Z, Yang CJ. 2016. Advance in phage display technology for bioanalysis. Biotechnol J. 11(6):732–745.
   PubMed Web of Science ®Google Scholar
• Ter Meulen J, Van Den Brink EN, Poon LLM, Marissen WE, Leung CSW, Cox F, Cheung CY, Bakker AQ, Bogaards JA, Van Deventer E, et al. 2006. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3(7):e237.
   PubMed Web of Science ®Google Scholar
• Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, et al. 2015. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Lancet Oncol. 16(7):763–774.
   PubMed Web of Science ®Google Scholar
• Tian H, Davidowitz E, Lopez P, He P, Schulz P, Moe J, Sierks MR. 2015. Isolation and characterization of antibody fragments selective for toxic oligomeric tau. Neurobiol Aging. 36(3):1342–1355.
   PubMed Web of Science ®Google Scholar
• Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, et al. 2020. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 9(1):382–385.
   PubMed Web of Science ®Google Scholar
• Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, et al. 2018. First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5–17 months old infants and children. PLoS One. 13(12):e0208328.
   PubMed Web of Science ®Google Scholar
• Tiumentseva M, Morozova V, Zakabunin A, Korobko D, Malkova N, Filipenko M, Tikunova N. 2016. Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis. Immunogenetics. 68(4):237–246.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Liu J, Valyi-Nagy T, Shukla D. 2011. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem. 286(28):25406–25415.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Tarbutton MS, Shukla D. 2015. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies. Molecules. 20(2):2707–2727.
   PubMed Web of Science ®Google Scholar
• Torikai M, Higuchi H, Yamamoto N, Ishikawa D, Fujita H, Taguchi K, Sakai F, Soejima K, Nakashima T. 2020. A novel monoclonal antibody cross-reactive with both human and mouse a9 integrin useful for therapy against rheumatoid arthritis. J Biochem. 168(3):231–241.
   PubMed Web of Science ®Google Scholar
• Tyumentseva MA, Morozova VV, Lebedev LR, Babkin IV, Tikunova NV. 2013. Presence of aberrant VH6 domains in anti-interferon-γ autoantibodies in multiple sclerosis. Hum Antibodies. 22(1-2):31–49.
   PubMedGoogle Scholar
• Van Groen T, Kadish I, Funke SA, Bartnik D, Willbold D. 2013. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice. J Alzheimers Dis. 34(3):609–620.
   PubMed Web of Science ®Google Scholar
• Van Groen T, Wiesehan K, Funke SA, Kadish I, Nagel-Steger L, Willbold D. 2008. Reduction of Alzheimer’s disease amyloid plaque load in transgenic mice by D3, a D-enantiomeric peptide identified by mirror image phage display. ChemMedChem. 3(12):1848–1852.
   PubMed Web of Science ®Google Scholar
• Vazquez SE, Ferré EMN, Scheel DW, Sunshine S, Miao B, Mandel-Brehm C, Quandt Z, Chan AY, Cheng M, German M, et al. 2020. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide phip-seq. Elife. 9:e55053.
   PubMed Web of Science ®Google Scholar
• Wahlberg E, Rahman MM, Lindberg H, Gunneriusson E, Schmuck B, Lendel C, Sandgren M, Löfblom J, Ståhl S, Härd T. 2017. Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β. Sci Rep. 7(1):5949.
   PubMedGoogle Scholar
• Walter JD, Scherer M, Hutter CAJ, Garaeva AA, Zimmermann I, Wyss M, Rheinberger J, Ruedin Y, Earp JC, Egloff P, et al. 2022. Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance. EMBO Rep. 23(4):e54199.
   PubMed Web of Science ®Google Scholar
• Wang J, Tan X, Guo Q, Lin X, Huang Y, Chen L, Zeng X, Li R, Wang H, Wu X. 2020. FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin. Pharmacol Res. 152:104575.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang J, Li N, Ma J, Gu Z, Yu L, Fu X, Liu X. 2016. Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice. Brain Res. 1635:169–179.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu C, Wang H, Jiang C. 2021. Identification of nanobodies against hepatocellular carcinoma marker glypican-3. Mol Immunol. 131:13–22.
   PubMed Web of Science ®Google Scholar
• Wang YP, Liu IJ, Chung MJ, Wu HC. 2020. Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck. Oral Oncol. 106:104689.
   PubMed Web of Science ®Google Scholar
• Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, Fels JM, He S, James RM, de La Vega MA, Zhu W, et al. 2017. Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses. Cell. 169(5):878–890.e15.
   PubMed Web of Science ®Google Scholar
• Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, et al. 2016. A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses. Science. 354(6310):350–354.
   PubMed Web of Science ®Google Scholar
• Wei J, Hameed M, Wang X, Zhang J, Guo S, Anwar MN, Pang L, Liu K, Li B, Shao D, et al. 2020. Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo. Antiviral Res. 174:104673.
   PubMed Web of Science ®Google Scholar
• Wenzel EV, Bosnak M, Tierney R, Schubert M, Brown J, Dübel S, Efstratiou A, Sesardic D, Stickings P, Hust M. 2020. Human antibodies neutralizing diphtheria toxin in vitro and in vivo. Sci Rep. 10(1):1–21.
   PubMed Web of Science ®Google Scholar
• Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, Norris JS. 2003. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob Agents Chemother. 47(4):1301–1307.
   PubMed Web of Science ®Google Scholar
• Whaley SR, English DS, Hu EL, Barbara PF, Belcher AM. 2000. Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly. Nature. 405(6787):665–668.
   PubMed Web of Science ®Google Scholar
• Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D. 2003. Selection of D-amino-acid peptides that bind to Alzheimer’s disease amyloid peptide Aβ1-42 by mirror image phage display. ChemBioChem. 4(8):748–753.
   PubMed Web of Science ®Google Scholar
• Williams A, Baird LG. 2003. DX-88 and HAE: a developmental perspective. Transfus Apher Sci. 29:255–258.
   Google Scholar
• Wu CH, Lan CH, Wu KL, Wu YM, Jane WN, Hsiao M, Wu HC. 2018. Hepatocellular carcinoma-targeted nanoparticles for cancer therapy. Int J Oncol. 52(2):389–401.
   PubMed Web of Science ®Google Scholar
• Xia L, Teng Q, Chen Q, Zhang F. 2020. Preparation and characterization of anti-GPC3 nanobody against hepatocellular carcinoma. Int J Nanomed. 15:2197–2205.
   PubMed Web of Science ®Google Scholar
• Xue D, Zhao M, Wang YJ, Wang L, Yang Y, Wang SW, Zhang R, Zhao Y, Liu RT. 2012. A multifunctional peptide rescues memory deficits in Alzheimer’s disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis. Neurobiol Dis. 46(3):701–709.
   PubMed Web of Science ®Google Scholar
• Xue W, Zhao Q, Li P, Zhang R, Lan J, Wang J, Yang X, Xie Z, Jiang S. 2019. Identification and characterization of a novel nanobody against duck hepatitis A virus type 1. Virology. 528:101–109.
   PubMed Web of Science ®Google Scholar
• Yacoby I, Bar H, Benhar I. 2007. Targeted drug-carrying bacteriophages as antibacterial nanomedicines. Antimicrob Agents Chemother. 51(6):2156–2163.
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Ito S, Masuda T, Couraud PO, Ohtsuki S. 2020. Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo. J Control Release. 321:744–755.
   PubMed Web of Science ®Google Scholar
• Yao VJ, D’Angelo S, Butler KS, Theron C, Smith TL, Marchiò S, Gelovani JG, Sidman RL, Dobroff AS, Brinker CJ, et al. 2016. Ligand-targeted theranostic nanomedicines against cancer. J Control Release. 240:267–286.
   PubMed Web of Science ®Google Scholar
• Yata T, Lee KY, Dharakul T, Songsivilai S, Bismarck A, Mintz PJ, Hajitou A. 2014. Hybrid nanomaterial complexes for advanced phage-guided gene delivery. Mol Ther Nucleic Acids. 3(8):e185.
   PubMedGoogle Scholar
• Yoo SY, Jin HE, Choi DS, Kobayashi M, Farouz Y, Wang S, Lee SW. 2016. M13 bacteriophage and adeno-associated virus hybrid for novel tissue engineering material with gene delivery functions. Adv Healthc Mater. 5(1):88–93.
   PubMed Web of Science ®Google Scholar
• Yun Huang Y, Fang N, Ru Luo H, Gao F, Zou Y, Li Zhou L, Ping Zeng Q, Song Fang S, Xiao F, Zheng Q. 2020. RP1, a RAGE antagonist peptide, can improve memory impairment and reduce Aβ plaque load in the APP/PS1 mouse model of Alzheimer’s disease. Neuropharmacology. 180:108304.
   PubMed Web of Science ®Google Scholar
• Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A, Doria A, Van Venrooij WJ, Raats JMH. 2003. Recombinant anti-P protein autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci. 60(3):588–598.
   PubMed Web of Science ®Google Scholar
• Żelechowska K, Karczewska-Golec J, Karczewski J, Łoś M, Kłonkowski AM, Węgrzyn G, Golec P. 2016. Phage-directed synthesis of photoluminescent zinc oxide nanoparticles under benign conditions. Bioconjug Chem. 27(9):1999–2006.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wan X, Zheng X, Shao X, Liu Q, Zhang Q, Qian Y. 2014. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer’s disease mice. Biomaterials. 35(1):456–465.
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen Y, Yang L, Zhu J. 2019. Construction and characterization of porcine single-chain fragment variable antibodies that neutralize transmissible gastroenteritis virus in vitro. Arch Virol. 164(4):983–994.
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo Z, He B, Dai W, Zhang H, Wang X, Zhang Q. 2018. The improved delivery to breast cancer based on a novel nanocarrier modified with high-affinity peptides discovered by phage display. Adv. Healthcare Mater. 7(20):1800269.
   Web of Science ®Google Scholar
• Zhang S, Kostyuchenko VA, Ng TS, Lim XN, Ooi JSG, Lambert S, Tan TY, Widman DG, Shi J, Baric RS, et al. 2016. Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun. 7:13679.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhong M, Zhao P, Zhang X, Li Y, Wang X, Sun J, Lan W, Sun H, Wang Z, et al. 2019. Screening a specific Zn(ii)-binding peptide for improving the cognitive decline of Alzheimer’s disease in APP/PS1 transgenic mice by inhibiting Zn2+-mediated amyloid protein aggregation and neurotoxicity. Biomater Sci. 7(12):5197–5210.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li Y, Wu X, Li L, Liu J, Wang Y, Liu Y, Li Q, Wang Z. 2020. Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies. Cancer Biol Ther. 21(1):72–80.
   PubMed Web of Science ®Google Scholar
• Zhou WW, Lu S, Su YJ, Xue D, Yu XL, Wang SW, Zhang H, Xu PX, Xie XX, Liu RT. 2014. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease. Free Radic Biol Med. 74:50–63.
   PubMed Web of Science ®Google Scholar
• Zhu J, Tao P, Mahalingam M, Sha J, Kilgore P, Chopra AK, Rao V. 2019. A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells. Sci. Adv. 5(8):eaax0064.
   PubMed Web of Science ®Google Scholar